Cargando…

Specific Recognition of Breast Cancer Cells In Vitro Using Near Infrared-Emitting Long-Persistence Luminescent Zn(3)Ga(2)Ge(2)O(10):Cr(3+) Nanoprobes

In this paper, near-infrared emitting long-persistence luminescent Zn(3)Ga(2)Ge(2)O(10):Cr(3+) (ZGG) nanoparticles with diameters of 30–100 nm and bright luminescence were prepared by a sol–gel synthesis method. After the surface amination, the nanoparticles were further bioconjugated with breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinlei, Shi, Junpeng, Shen, Jiangshan, Man, Huizi, Wang, Mingxi, Zhang, Hongwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223935/
https://www.ncbi.nlm.nih.gov/pubmed/30464964
http://dx.doi.org/10.1007/s40820-014-0026-0
Descripción
Sumario:In this paper, near-infrared emitting long-persistence luminescent Zn(3)Ga(2)Ge(2)O(10):Cr(3+) (ZGG) nanoparticles with diameters of 30–100 nm and bright luminescence were prepared by a sol–gel synthesis method. After the surface amination, the nanoparticles were further bioconjugated with breast cancer-specific monoclonal antibody (anti-EpCAM) to form ZGG-EpCAM nanoprobes which can specifically target breast cancer cell lines (MCF7) in vitro. The results of in vitro images show that the luminescence signals from the cells treated with ZGG-EpCAM nanoprobes are stronger than those from cells treated with ZGG-unconjugated antibody, indicating that the prepared ZGG-EpCAM nanoprobes possessed excellent specific recognition capability. Furthermore, due to their long afterglow properties, the imaging could persist more than 1 h. Therefore, these nanoprobes could not only provide a high specificity detection method for cancer cells but also realize the long-time monitoring. Developed near-infrared emitting long-persistence luminescent nanoprobes will be expected to find new perspectives for cell therapy research and diagnosis applications.